EGFR and neoplasm: Another preclinical model involving human-induced pluripotent stem cell-derived teratoma xenograft model showed that EGFR806 CAR T cells, which are able to recognize low density EGFR, both selectively and effectively targeted EGFR-expressing tumor cells (52).